HOST Therabiomics Wants to Develop Dietary Compound into Bowel-disease Treatment
News
HOST Therabiomics hopes to develop the dietary compound HOST-G904, which improved the composition of gut bacteria without increasing gas, into a treatment for inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and other ... Read more